Table 1.
Reference | Drug | Observed variable | Para | Trb | kprol c | Drug effect | |
---|---|---|---|---|---|---|---|
Minami (1998) | [14] | Paclitaxel | WBC | 4 | Lag time | Zero order | E max |
Friberg (2000) | [15] | DMDC | ANC | 7 | 9 | Zero order | E max |
Zamboni (2001) | [16] | Topotecan | ANC | 4 | 1 | Zero order | E max |
Friberg (2002) | [17] | Docetaxel, etoposide, and paclitaxel | ANC WBC | 5 | 3 | First order | Linear |
Panetta (2003) | [18] | TMZ | ANC | 5 | 2 | First order | E max |
Bulitta (2009) | [19] | Paclitaxel paclitaxel EL | ANC | 5 | 1d | Zero order | Linear |
WBC white blood cell count, ANC absolute neutrophil count, TMZ temozolomide
aNumber of parameters estimated in pharmacodynamic model
bNumber of transit compartments or if lag time is used
cProliferation rate constant
dMaturating pool of cells